BACKGROUND: The @entity221 ( @entity221 ) is prevalent among @entity1 with enterocutaneous @entity292 and is associated with poor outcomes. The present study aimed to explore the role of enteral nutrition (EN) therapy on thyroid function among @entity1 with enterocutaneous @entity292 and @entity221 . METHODS: We conducted a retrospective observational study among @entity1 with enterocutaneous @entity292 between January 2013 and April 2014. All enrolled @entity1 received EN therapy. Thyroid function and other parameters were measured. RESULTS: After administration of 4  weeks of EN therapy, @entity221 was resolved in 66 @entity1 (Group A), while it persisted in 14 @entity1 (Group B). The overall treatment success rate was 82.50  %. There were no significant differences between groups A and B at baseline for all parameters, except for the time from admission to start of EN therapy. The logistic analysis revealed that the time from admission to start of EN therapy was a significant independent indicator for achieving resolution of @entity221 in our cohort. CONCLUSIONS: This retrospective observational cohort study demonstrated that EN therapy can aid in the resolution of @entity221 among @entity1 with enterocutaneous @entity292 . These findings confirm the benefit of EN in the treatment of enterocutaneous @entity292 .

Role of enteral nutrition in XXXX : a retrospective observational study.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity292 :: ('MESH:D005402', 'Disease') :: ['fistula'] @entity221 :: ('MESH:D005334', 'Disease') :: ['nonthyroidal illness syndrome', 'NTIS']
@entity221 :: (MESH:D005334,Disease) :: ['nonthyroidal illness syndrome']
